Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MEDIFAST INCMED · Entity 6587 | Director | May 26, 2026 | May 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MEDIFAST INC
Report date May 26, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,225 |
Reported balance
After 2026-05-26 transaction · row 1
1 source rowRow 1 · 2026-05-26 · Grant · Acquired 11,680 · Balance 31,225 F1: These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 26, 2026 Filed May 28, 2026 23:31 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 11,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-038974 · wk-form4_1780011108.xml · nonDerivative · entry 1 Geary Elizabeth A. · CIK 0001981550 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,225 F1 · shares: These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 23:03 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 11,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-033182 · wk-form4_1750978999.xml · nonDerivative · entry 1 Geary Elizabeth A. · CIK 0001981550 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,545 F1 · shares: These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 21:49 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 6,596 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-029659 · wk-form4_1719265760.xml · nonDerivative · entry 1 Geary Elizabeth A. · CIK 0001981550 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,377 F1 · shares: 6,596 restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These awards are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025. Read SEC document |
| June 15, 2023 Filed Jun 21, 2023 00:28 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 1,781 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-022797 · wk-form4_1687307279.xml · nonDerivative · entry 1 Geary Elizabeth A. · CIK 0001981550 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,781 F1 · shares: Represents the right to receive 1,781 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 15, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.